Streetbeat News

Equity Actions

IVP

Inspire Veterinary Partners' stock is trading lower following the filing of a prospectus for a public offering of up to $5 million.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:27 pm

MRK

Merck & Co Inc. (NYSE:MRK) stock has seen a 12.80% increase over the past month and a 6.02% increase over the past year, currently trading at $117.10. The company's P/E ratio of 65.01 is higher than the Pharmaceuticals industry average of 38.1, which could suggest that Merck is expected to perform better than its peers or that it may be overvalued. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for a comprehensive investment decision.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 5:15 pm

NOW

On CNBC, Jason Snipe revealed that he has reduced his investment position in ServiceNow (NOW). This information could influence investor sentiment and potentially impact ServiceNow's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:14 pm

IRM

STX

Jenny Harrington announced on CNBC that she has sold her positions in Seagate Technology and Iron Mountain. This could indicate a lack of confidence in these companies or a strategic portfolio adjustment.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:14 pm

IMUX

Immunic, Inc. (NASDAQ:IMUX) announced a private placement of up to $240 million in three tranches. The first tranche is $80 million at $1.43 per share, with the second and third tranches contingent on certain conditions. The company expects gross proceeds between $160 and $240 million and provided a business update. IMUX shares are relatively flat, with a slight increase of 0.64% at $1.44.

Portfolio Pulse from Erica Kollmann

January 05, 2024 | 5:03 pm

NVDA

BofA Securities analysts predict NVIDIA's generative AI dominance could generate approximately $100B in incremental free cash flow over the next two years. They anticipate NVIDIA will use $30B-$35B of this for stock buybacks.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:58 pm

CPRX

Catalyst Pharmaceuticals' stock is trading lower following the announcement of a $150 million public offering, which will issue 10 million shares at $15 each.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:49 pm

VYGR

Voyager Therapeutics has announced the pricing of its $100M offering, which consists of 7,777,778 shares at $9 per share, causing its stock to trade lower.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:32 pm

IVP

Inspire Veterinary Partners Inc has filed a prospectus with the SEC for a public offering of its Class A common stock, aiming to raise up to $5 million.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:20 pm

EGLE

Eagle Bulk Shipping (NYSE:EGLE) has received mixed analyst ratings over the past three months, with 2 bullish and 2 indifferent ratings. The average 12-month price target is now $53.3, down from $64.00, indicating a 16.72% decrease. Analysts from Noble Capital Markets, B. Riley Securities, Jefferies, and Stifel have provided recent evaluations, with some maintaining and others lowering their price targets. Eagle Bulk Shipping's financial health shows challenges, with a -55.42% revenue decline, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio of 0.85.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 4:01 pm